RNA - Avidity Biosciences Inc Ordinary Shares (Healthcare: Biotechnology) Projected Earnings Date: 0000-02-29    (Delayed quote data   2025-01-02)
Last
 31.18		 Change
 ⇑ +2.10   (+7.22%)		 Volume
  1,297,206
Open
 29.61		 High
 31.63		 Low
 29.39
8EMA (Daily)
 30.77		 40EMA (Daily)
 36.76		 50EMA (Daily)
 37.80		 STO (Daily)
 14.494		 MACD Hist (Daily)
 0.096
8EMA (Weekly)
 35.437		 40EMA (Weekly)
 35.76		 50EMA (Weekly)
 33.92		 STO (Weekly)
 5.711		 MACD Hist (Weekly)
 -4.620
Company Profile
Avidity Biosciences Inc is a bio-technology company. The company develops novel Antibody Oligonucleotide Conjugates therapies designed to overcome the current limitations of oligonucleotide therapies in order to treat a wide range of serious diseases. Its product candidate AOC 1001, is designed to treat a rare monogenic muscle disease.
optionchance optionchance
⇒ Home | Chart and Research | Education | About Us  

Disclaimer: All information provided is for informational purposes only and not intended for trading purposes or advice. The quotes and charts are not real time and have delays of at least 20 minutes. Data accuracy cannot be guaranteed as errors will occur. Please do not rely on the above information to make your stock/option trades. Neither OptionChance.com nor any of independent data providers is liable for any informational errors, incompleteness, or delays, or for any actions taken in reliance on information contained herein.

Questions or Comments: support@optionchance.com
Copyright © 2025 OptionChance.com